India is the largest provider of generic drugs globally which contributes to 50% of global demand for various vaccines of which 40% of generic demand in the US and 25% of all the medicinal supplies to the UK. It has placed itself in a prominent position. As the country has a large pool of scientists and engineers, the industry has the potential to reform the pharma industry.
Currently, 80% of the antiretroviral worldwide supply met by the Indian Pharmaceutical industry. Considering the analysis made by the expert’s Indian Pharmaceutical industry expected to touch $130 billion by 2030. Pharmaceutical industries are giving a tough competition to attain a top position. Below is the list of the top 5 GMP and WHO Pharma companies in India.
Sun Pharmaceutical Industries Limited:
Sun Pharmaceutical was founded in 1993. It currently has 8 directors present as per the MCA records. Today it has acquired a reputed position placing itself on one of the largest pharmaceutical companies from India and the fifth-largest specialty generic company in the world. Sun Pharma acquired Ranbaxy Laboratories in April 2014. This pharmaceutical company has become a leading contributor and gained the trust of the masses. Its authorized capital is 600cr., having paid-up capital over 200 cr.
Q3 report:
Sun Pharma raised a net profit of Rs 1,852.48 Crore for its Q3.
Aurobindo Pharma:
Aurobindo Pharma was established in 1986. 11 directors are associated with the company as per MCA records. Initially, the company carried out its operations with a small unit based in Pondicherry. Aurobindo Pharma had entered into an agreement in 2020 with Covaxx to develop, commercialize and manufacture COVID-19 vaccine for India and United Nations Children Fund. This is a great initiative and contribution made towards society. Its authorized capital is 76cr., having paid-up capital over 58.5 cr.
Q3 report:
Aurobindo Pharma announced a hike of four times profit in its Q3 for rs 2946.32
Lupin Limited:
Lupin Limited Mumbai-based multinational pharmaceutical company was established in the year 1983. It has 11 directors associated with the company as per the MCA record. Lupin research on various areas namely Generics Research, Process Research, Pharmaceutical Research, Advanced Drug Delivery Systems Research Intellectual Property Management. Lupin Limited has become a priority for several processes across India. Its authorized capital is 200cr., and having paid-up capital over 90.5 cr.
Q3 report:
Lupin Limited earned a net profit of Rs 438.25 crore in its Q3
Cipla Limited:
Cipla Limited located in Mumbai was founded in 1935. It changed its name to Cipla Limited in 1984. Cipla has 10 directors as per the MCA record. Cipla launched Deferiprone, the first oral iron chelator in 1995. It understood the need to reach out to each individual that requires medical attention. Cipla produces medicines for antiretrovirals, for HIV treatment at a minimal cost. It focuses on developing new formulations, drug delivery systems, and APIs.
It has created a great sense of trust among its widely based customers. Its authorized capital is 175 cr., and having paid-up capital over 162 cr.
Q3 report:
Cipla’s net profit jumps 113% to 748.2 crore, which is a rise of 18%.
Dr. Reddy’s:
Dr. Reddy’s Laboratory is a multinational pharmaceutical company established in 1984. As per the MCA record, it currently has 10 directors. Dr. Reddy’s Laboratory makes sure these generic medications are affordable. The brand emphasizes developing products that are available without a doctor’s prescription. Dr. Reddy had recently sought permission from the Drug Controller General of India to conduct a vaccine trial on the children. The brand has become favorite and trustable among the citizens. It has an authorized capital of 120cr., and having paid-up capital of over 83 cr.
Q3 report:
Dr. Reddy’s Laboratories reported a profit of Rs 19.8 crore.
For more information please visit TheCompanyCheck
